Akporiaye ET - Search Results

1

Expression of an antisense transforming growth factor-beta1 transgene reduces tumorigenicity of EMT6 mammary tumor cells.

Park JA, Wang E, Kurt RA, Schluter SF, Hersh EM, Akporiaye ET. Park JA, et al. Among authors: akporiaye et. Cancer Gene Ther. 1997 Jan-Feb;4(1):42-50. Cancer Gene Ther. 1997. PMID: 9012450

2

Transforming growth factor beta inhibits the antigen-presenting functions and antitumor activity of dendritic cell vaccines.

Kobie JJ, Wu RS, Kurt RA, Lou S, Adelman MK, Whitesell LJ, Ramanathapuram LV, Arteaga CL, Akporiaye ET. Kobie JJ, et al. Among authors: akporiaye et. Cancer Res. 2003 Apr 15;63(8):1860-4. Cancer Res. 2003. PMID: 12702574

3

Studies of in vivo recruitment and activation of cytotoxic lymphocytes using a gelatin-sponge model of concomitant tumor immunity.

Park JA, Brown RA, Kurt RA, Akporiaye ET. Park JA, et al. Among authors: akporiaye et. Int J Cancer. 1995 Aug 9;62(4):421-7. doi: 10.1002/ijc.2910620411. Int J Cancer. 1995. PMID: 7543457

4

T lymphocytes infiltrating sites of tumor rejection and progression display identical V beta usage but different cytotoxic activities.

Kurt RA, Park JA, Panelli MC, Schluter SF, Marchalonis JJ, Carolus B, Akporiaye ET. Kurt RA, et al. Among authors: akporiaye et. J Immunol. 1995 Apr 15;154(8):3969-74. J Immunol. 1995. PMID: 7706735

5

Interferon gamma (IFNgamma) gene transfer of an EMT6 tumor that is poorly responsive to IFNgamma stimulation: increase in tumor immunogenicity is accompanied by induction of a mouse class II transactivator and class II MHC.

Panelli MC, Wang E, Shen S, Schluter SF, Bernstein RM, Hersh EM, Stopeck A, Gangavalli R, Barber J, Jolly D, Akporiaye ET. Panelli MC, et al. Among authors: akporiaye et. Cancer Immunol Immunother. 1996 Feb;42(2):99-107. doi: 10.1007/s002620050258. Cancer Immunol Immunother. 1996. PMID: 8620527 Free PMC article.

6

Phase I study of immunotherapy of malignant melanoma by direct gene transfer.

Hersh EM, Akporiaye E, Harris D, Stopeck AT, Unger EC, Warneke JA, Kradjian SA. Hersh EM, et al. Hum Gene Ther. 1994 Nov;5(11):1371-84. doi: 10.1089/hum.1994.5.11-1371. Hum Gene Ther. 1994. PMID: 7893808 Clinical Trial. No abstract available.

7

Mammalian expression vector with two multiple cloning sites for expression of two foreign genes.

Tsang TC, Harris DT, Akporiaye ET, Chu RS, Brailey J, Liu F, Vasanwala FH, Schluter SF, Hersh EM. Tsang TC, et al. Among authors: akporiaye et. Biotechniques. 1997 Jan;22(1):68. doi: 10.2144/97221bm13. Biotechniques. 1997. PMID: 8994649 Free article. No abstract available.

8

Phase I study of direct gene transfer of an allogeneic histocompatibility antigen, HLA-B7, in patients with metastatic melanoma.

Stopeck AT, Hersh EM, Akporiaye ET, Harris DT, Grogan T, Unger E, Warneke J, Schluter SF, Stahl S. Stopeck AT, et al. Among authors: akporiaye et. J Clin Oncol. 1997 Jan;15(1):341-9. doi: 10.1200/JCO.1997.15.1.341. J Clin Oncol. 1997. PMID: 8996161 Clinical Trial.

9

Clinical aspects of intratumoral gene therapy.

Akporiaye ET, Hersh E. Akporiaye ET, et al. Curr Opin Mol Ther. 1999 Aug;1(4):443-53. Curr Opin Mol Ther. 1999. PMID: 11713758 Review.

10

Human monoclonal natural autoantibodies against the T-cell receptor inhibit interleukin-2 production in murine T cells.

Robey IF, Schluter SF, Akporiaye E, Yocum DE, Marchalonis JJ. Robey IF, et al. Immunology. 2002 Apr;105(4):419-29. doi: 10.1046/j.1365-2567.2002.01389.x. Immunology. 2002. PMID: 11985662 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

72 results

Search Page

Filters